IRIS - Res&Arch Institutional Research Information System - Research & Archive

LUDOVINI, VIENNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 813
EU - Europa 590
AS - Asia 583
SA - Sud America 122
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.121
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 777
SG - Singapore 267
IT - Italia 165
IE - Irlanda 120
BR - Brasile 108
CN - Cina 102
HK - Hong Kong 85
DE - Germania 75
VN - Vietnam 61
RU - Federazione Russa 55
FI - Finlandia 34
SE - Svezia 30
FR - Francia 27
KR - Corea 24
GB - Regno Unito 21
CA - Canada 17
MX - Messico 13
AT - Austria 11
IN - India 10
PL - Polonia 10
RO - Romania 9
ES - Italia 7
UA - Ucraina 7
ZA - Sudafrica 7
AR - Argentina 6
CH - Svizzera 6
JP - Giappone 5
TR - Turchia 5
IQ - Iraq 4
BD - Bangladesh 3
ID - Indonesia 3
MA - Marocco 3
NL - Olanda 3
PK - Pakistan 3
PY - Paraguay 3
BG - Bulgaria 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
GR - Grecia 2
JO - Giordania 2
SV - El Salvador 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EU - Europa 1
GN - Guinea 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
NP - Nepal 1
OM - Oman 1
PW - Palau 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 2.121
Salva come PNG Salva come JPEG
Città #
Singapore 183
Chandler 168
Dublin 120
Hong Kong 85
Perugia 85
Ashburn 52
Munich 52
Boardman 47
San Mateo 37
Santa Clara 36
Beijing 25
Dong Ket 25
Seoul 23
Altamura 22
Ann Arbor 21
Helsinki 21
Medford 21
Princeton 21
Los Angeles 19
Lawrence 18
Moscow 17
Andover 15
Redmond 14
Ho Chi Minh City 13
São Paulo 12
Warsaw 10
Bucharest 9
Dearborn 9
Mexico City 9
New York 9
Piscataway 9
The Dalles 9
Chennai 7
Johannesburg 7
Montreal 7
Vienna 7
Nuremberg 6
Saint Petersburg 6
San Paolo di Civitate 6
Turku 6
Wilmington 6
Brasília 5
Falkenstein 5
Frankfurt am Main 5
Hanoi 5
Hefei 5
Houston 5
Tokyo 5
Arezzo 4
Atlanta 4
Denver 4
Guangzhou 4
Haiphong 4
Norwalk 4
Rio de Janeiro 4
Seattle 4
Stockholm 4
Tianjin 4
Ankara 3
Boston 3
Calgary 3
Canoas 3
Chicago 3
Columbus 3
Curitiba 3
Dallas 3
Erbil 3
Formia 3
London 3
Montalto delle Marche 3
Orem 3
Paris 3
Phoenix 3
Poplar 3
Redwood City 3
Rome 3
Salvador 3
Vicenza 3
Amman 2
Aracaju 2
Asso 2
Baoding 2
Bexley 2
Biên Hòa 2
Bologna 2
Campinas 2
Formosa 2
Lappeenranta 2
Mumbai 2
Phủ Lý 2
Qingdao 2
Quảng Ngãi 2
San Francisco 2
San Salvador 2
Sofia 2
São Gabriel 2
Amsterdam 1
Annapolis 1
Anápolis 1
Asunción 1
Totale 1.449
Salva come PNG Salva come JPEG
Nome #
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 178
Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer 109
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer 104
A machine learning approach applied to Reverse Phase Protein Microarray data for pathways activation mapping of KRAS wild type and mutated adenocarcinomas of the lung 93
Large Cell Neuroendocrine Carcinoma Transformation and EGFR-T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer 88
Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma 84
Higher tlr7 gene expression predicts poor clinical outcome in advanced nsclc patients treated with immunotherapy 81
Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy 79
Modified gene expression of alveolar-capillar membrane, extracellular matrix and membrane proteins after induction chemotherapy for Non-Small Cell Lung Cancer 79
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study 79
Pathway Activation Mapping of Kras Wild Type and Mutated Adenocarcinomas of the Lung: New Implications For Patient Stratification For Map Kinase Pathway Inhibition 77
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients 77
INSL4 as prognostic marker for proliferation and invasiveness in non-small-cell lung cancer 76
Liquid Biopsy in early Breast Cancer: A preliminary Report 73
Dynamic network topologies analysis in proteomics data of NSCLC cell lines using a new pipeline based on machine learning tools 72
Variations in gene expression of lung macromolecules after induction chemotherapy for lung cancer 70
Prognostic implications of epidermal growth factor receptor, KRAS and BRAF gene mutations in resected non-small cell lung cancer patients 68
PD-L1 quantification across tumor types using the reverse phase protein microarray: Implications for precision medicine 68
Sensitivity to immune checkpoint blockade in advanced non-small cell lung cancer patients with EGFR exon 20 insertion mutations 67
Clinical outcomes to pemetrexed-based versus non-pemetrexed-based platinum doublets in patients with KRAS-mutant advanced non-squamous non-small cell lung cancer 60
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab 54
Serum level changes of matrix metalloproteinases 2 and 9, vascular endothelial growth factor and epidermal growth factor receptor during platinum-based chemotherapy in advanced non-small cell lung cancer patients 54
Detection of egfr mutations in plasma cell-free tumor dna of tki-treated advanced-nsclc patients by three methodologies: Scorpion-arms, pnaclamp, and digital pcr 54
Antigen-Presenting Signaling Events in the Tumor Ecology Associate with Response to Anti-PD-1 Treatment in Lung Cancer 53
Prevalence and spectrum of brca germline variants in central Italian high risk or familial breast/ovarian cancer patients: A monocentric study 53
RET Rearrangement as a Predictor of Unresponsiveness to Immunotherapy in Non-Small Cell Lung Cancer: Report of Two Cases with Review of the Literature 44
Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two cases 42
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations 40
Assessment of TILs, IDO-1 and PD-L1 in resected non small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications. 40
RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion 39
Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs 37
Totale 2.192
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.279
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.279
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149 0 0 0 0 0 6 1 4 6 2 3 27
2021/2022181 1 25 3 6 3 2 0 63 24 14 16 24
2022/2023438 21 84 5 54 39 30 0 21 163 3 15 3
2023/2024175 12 8 16 5 5 1 40 2 7 4 38 37
2024/2025502 7 35 42 16 54 41 14 42 81 45 75 50
2025/2026636 76 87 67 162 184 60 0 0 0 0 0 0
Totale 2.192